Buscar
SeaStar Medical Holding Corp
ICUAñadir a la lista de seguimiento
3.130USD
-0.050-1.57%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
12.50MCap. mercado
PérdidaP/E TTM
Más Datos de SeaStar Medical Holding Corp Compañía
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Información de SeaStar Medical Holding Corp
Símbolo de cotizaciónICU
Nombre de la empresaSeaStar Medical Holding Corp
Fecha de salida a bolsaJan 26, 2021
Director ejecutivoSchlorff (Eric)
Número de empleados19
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 26
Dirección3513 Brighton Blvd
CiudadDENVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80216
Teléfono18444278100
Sitio Webhttps://seastarmedical.com
Símbolo de cotizaciónICU
Fecha de salida a bolsaJan 26, 2021
Director ejecutivoSchlorff (Eric)
Ejecutivos de SeaStar Medical Holding Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
15.81K
+65.07%
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
12.27K
+32.61%
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
11.02K
+65.34%
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
6.69K
+59.82%
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
4.27K
+93.74%
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Mr. Michael Hollan Messinger, CPA
Mr. Michael Hollan Messinger, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
15.81K
+65.07%
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
12.27K
+32.61%
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
11.02K
+65.34%
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
6.69K
+59.82%
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
4.27K
+93.74%
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de SeaStar Medical Holding Corp?
Los cinco principales accionistas de SeaStar Medical Holding Corp son: Mr. Eric Schlorff
¿Cuántas instituciones poseen acciones de SeaStar Medical Holding Corp (ICU)?
A fecha de 2026Q1, 51 instituciones poseen acciones de SeaStar Medical Holding Corp, con un valor de mercado combinado de aproximadamente 94.83K, lo que representa el 2.37% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -86458.00.